Abstract
Parkinson’s disease (PD) is characterized by α-synuclein accumulation and dopaminergic neuron degeneration, with dopamine (DA) oxidation emerging as a key pathological driver. However, the mechanisms underlying this neurotoxic process remain unclear. Using PD patient-derived and CRISPR-engineered induced pluripotent stem cell midbrain dopaminergic neurons lacking DJ-1, we identified defective sequestration of cytosolic DA into synaptic vesicles, which culminated in DA oxidation and α-synuclein pathology. In-depth proteomics, state-of-the-art imaging, and ultrasensitive DA probes uncovered that decreased vesicular monoamine transporter 2 (VMAT2) protein and function impaired vesicular DA uptake, resulting in reduced vesicle availability and abnormal vesicle morphology. Furthermore, VMAT2 activity and vesicle endocytosis are processes dependent on adenosine 5′-triphosphate (ATP), which is notably reduced in DJ-1–deficient dopaminergic neurons. ATP supplementation restored vesicular function and alleviated DA-related pathologies in mutant dopaminergic neurons. This study reveals an ATP-sensitive mechanism that regulates DA homeostasis through VMAT2 and vesicle dynamics in midbrain dopaminergic neurons, highlighting enhanced DA sequestration as a promising therapeutic strategy for PD.
All Related Versions
Funding Information
  • Helmholtz Association (ExNet-0041-Phase2-3 (‘SyNergy-HMGU’))
  • Hector Fellow Academy
  • European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (948027)
  • Germany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)
  • Germany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)
  • Germany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)
  • Rise up! programme of the Boehringer Ingelheim Foundation
  • DFG, Heisenberg programme (447395247)
  • Bundesministerium für Bildung und Forschung under the aegis of JPND (01ED2402A)
  • Helmholtz AssociationGermany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)

This publication has 100 references indexed in Scilit: